Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 147

Fundamental indexing over the cycle

Due to the tendency of stock prices to over and undershoot fundamentals over the economic cycle, both finance theory and empirical evidence suggests that ‘fundamentally weighted’ equity indices (FWIs) should, over time, outperform more traditional market-cap weighted equity indices (MCWIs). It’s also the case that FWIs endure periods of underperformance, usually arising when ‘momentum’ rather than valuation-based ‘regression to the mean’ is driving market performance.

Contrast cap-weight index and fundamental-weight index

As should be clear, MCWIs weight stocks according to their price-based market capitalisation. If the combined capitalisation of stocks in the S&P/ASX 200’s Index was $1.5 trillion, and company X had a market capitalisation of $150 billion, its weight in the index would be 10%.

By contrast, a FWI weights stocks according to non-price related measures of economic importance. In the case of the FTSE RAFI Australia 200 Index, for example, weights are based on four equally weighted factors: a company’s cash flow, dividends, sales and book value, with the first three of these measures averaged over the previous five years, and the last based upon the most recent accounting value.

As seen in the chart below, the upshot of this approach is that FWI’s will tend to be underweight stocks (compared to a MCWI) when their prices are relatively high compared to sales, earnings, book value and dividends, and over-weight these stocks when their prices are relatively low compared to these other non-price measures of a company’s importance.

Regression to the mean

In what’s known as ‘regression to the mean’ in value, to the extent relatively high price stocks eventually tend to underperform, and relatively low priced stocks eventually tend to outperform, finance theory suggests the FTSE RAFI Australian 200 Index should tend to outperform the S&P/ASX 200 over time.

Of course, this theory does not suggest FWIs will necessarily always outperform MCWIs. At least conceptually, the periods of over and under-performance of a FWI are outlined in the diagram below.

This diagram suggests that when stocks with a high price to fundamental value are continuing to outperform (as during the late stages of a speculative bull market at point B) or when stocks with a low price to fundamental value are continuing to underperform (as during the late stages of a bear market when despair is at its most extreme as at point A), FWIs will tend to underperform MCWIs.

FWIs then tend to outperform when beaten down cheap stocks rally relatively strongly in the early stage of a bull market (point C in the chart), and again when expensive stocks fall hardest in the early stage of a bear market (point D in the chart).

Simulated and actual performance

So much for the theory. Whether FWIs outperform MSWIs over time is ultimately an empirical question. Note that the FTSE RAFI Australia 200 Index was launched in August 2009. Index returns prior to launch are simulated based on Research Affiliates’ non-capitalisation weighted indexing system. Actual investment results may differ from simulated results.

As seen in the chart below, the FTSE RAFI Australia 200 Index (simulated plus actual) has tended to outperform the S&P/ASX 200 index over time, though relative performance has nonetheless varied over shorter time periods. Through most of the early 1990s, the RAFI Index outperformed, culminating in a strong surge of outperformance 1998-1999.

Relative Performance: S&P/ASX 200 Index v FTSE RAFI Australia 200 Index: May 1992-December 2015

Source: Research Affiliates and BetaShares. Graph shows performance of FTSE RAFI Australia 200 index relative to S&P/ASX 200 index, not ETF performance and does not allow for ETF management costs. You cannot invest directly in an index. Past performance is not an indicator of future performance of index or ETF.

The most abrupt period of underperformance was during the height of the dotcom bubble between mid-1998 and early 2000. But the Index then again outperformed as tech stocks crashed.

Recent RAFI underperformance

More recently, the RAFI Index has underperformed again, with a return of only 0.4% in 2015 compared to 2.6% for the S&P/ASX 200 Index. RAFI underperformed largely due to two factors: an overweight sector exposure to the underperforming resources sector, and an underweighting to the strongly performing health care sector.

In view of these cycles in relative performance, perhaps the most important statistic is that since the early 1990s, the since-inception outperformance of the RAFI Index over the S&P/ASX 200 Index has been 2.1% p.a.

Notwithstanding the recent underperformance, both finance theory and empirical evidence supports the view that the fundamental indexation strategy has the potential to add value to an investor’s portfolio.

 

David Bassanese is Chief Economist at BetaShares, a leading provider of ETFs. This article is for general information purposes only and neither Cuffelinks nor BetaShares are tax advisers. Readers should obtain professional, independent tax advice before making any investment decision.

BetaShares currently has two ETFs which track indices based on the RAFI fundamental indexation methodology – the BetaShares FTSE RAFI Australia 200 ETF (ASX: QOZ) and the BetaShares FTSE RAFI U.S. 1000 ETF (ASX: QUS).

 


 

Leave a Comment:

RELATED ARTICLES

The challenges of building a lazy portfolio

Global ETFs: insights into a multi-trillion-dollar industry

Australian ETFs: end of year reviews 2018

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.